By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
NZ services activity falls in January as employment, new business drop back
Z chases cheaper processing in new refinery procurement deal with Mobil
Freightways first-half sales rise 7%, profit dips on year-earlier one-time gain
Goodman Property offers to sell up to $100M of bonds to diversify funding
NZX boosts 2017 profit 62% as slimmed down agri unit trims costs, Farmers Weekly sold
Evolve shares fall 20% after profit warning
February 19th Morning Report
NZ dollar retreats on stronger US data, fails to break key resistance level
World Week Ahead: Fed, ECB in focus
MARKET CLOSE: NZ shares up, Tourism Holdings hits record with Auckland Airport, Fletcher Building gaining